Login
Toggle navigation
Videos
Categories
Trending
Dignitana 2020 Presentation - William Cronin, CEO Dignitana
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dignitana 2020 Presentation
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Mineros: Expanding Gold Production Across Latin America with Strategic Investments and Solid Dividends
00:10:00
The Rocket Fuel Formula: Igniting Hypergrowth in Your Business|Mike Droesch,Partner,Bessemer Venture Partners
00:10:00
NYU Trustee Evan Chesler on Life-Changing Scholarship | Evan R. Chesler - RETIRED PARTNER of Cravath, Swaine & Moore LLP
00:10:00
"Aamal Company's CEO, Mr. Rashid Al Mansoori, discusses the company's innovative strategies for sustainable growth and community development on Qatar Television."| Mr. Rashid Al Mansoori CEO of Aamal Company
00:10:00
Alternative Investments 101 | Michael Sager, Vice-President, Multi-Asset & Currency, CIBC Asset Management
00:10:00
Meriva Capital Markets to Sponsor the 4th International Dollar Markets Forum in Panama
00:00:00
Discussion Group CAP | NICOLÁS BURR G., CHIEF EXECUTIVE OFFICER, CAP SA
00:10:00
Environmental Milestones: From Oil Spills to Forest Resilience|Steven Hayward
00:10:00
The Role of Qualifications and Ethics in Finance: Insights from Wol Kolade | Wol Kolade, Managing Partner, Livingbridge.
00:10:00
Erik Carlson, Dish Network Corp. CEO, comments on Comcast Corp.'s successful bid for Sky Plc in a discussion about the evolving landscape of the telecommunications industry.|Hamid Akhavan is the President and CEO of DISH and EchoStar
00:10:00
Interview with Ian Lane: Insights on U.S. Energy Policy, Mining Critical Minerals, and Impacts of the Inflation Reduction Act
00:00:00
Glynn Wilson, CEO, TapImmune Inc